top of page

SCIENTIFIC EVENTS ORGANISATION

Conferences

Scientific events organisation.jpg

Conference sessions

Oral presentations Mathieu Vinken.jpg

Workshops and

courses

Mathieu Vinken Workshops.jpg.png

Seminars and webinars

Mathieu Vinken Seminars and Webinars.jpg
Conferences

(Co-)organisation of conferences

  • 16th Conference of the European Society for Toxicology In Vitro, Linz-Austria, 02-04/09/2010.

  • International Gap Junction Conference, Ghent-Belgium, 06-11/08/2011.

  • 17th Conference of the European Society for Toxicology In Vitro, Lisbon-Portugal, 16-19/10/2012.

  • 18th Conference of the European Society for Toxicology In Vitro, Egmond aan zee-The Netherlands, 10-13/06/2014.

  • International Gap Junction Conference, Valparaiso-Chili, 28/03-01/04/2015.

  • 19th Conference of the European Society for Toxicology In Vitro, Juan-Les-Pins-France, 17-21/10/2016.

  • 20th Conference of the European Society for Toxicology In Vitro, Berlin-Germany, 15-18/10/2018.

  • 8th Annual Meeting of the ASCCT: Computational toxicology: peeking into the clouds while keeping our feet on solid ground”, Gaithersburg-USA, 25-26/09/2019.

  • International Industrial and Environmental Toxicology Congress, Antalya-Turkey, 26-29/10/2019.

  • BelTox/IC-3Rs/INVITROM joint symposium, Brussels-Belgium, 21-22/11/2019. 

  • 11th Virtual World Congress on Alternatives and Animal Use in the Life Sciences, 23/08-02/09/2021.

  • 55th Congress of the European Societies of Toxicology, Virtual Conference, 27/09-01/10/2021.

  • International Colloquium on Gap Junctions and Cancer, Sao Paulo-Brazil, 10-14/07/2023.

  • 12th World Congress on Alternatives and Animal Use in the Life Sciences, Niagara Falls-Canada, 27-31/08/2023.

  • 57th Congress of the European Societies of Toxicology, Ljubljana-Slovenia, 10-13/09/2023.

  • 58th Congress of the European Societies of Toxicology, Copenhagen-Denmark, 08-11/09/2024.

  • 5th Latin American Congress of Alternative Methods to the Use of Experimental Animals, Bogota-Colombia, 16-20/09/2024.

  • Microphysiological World Summit 2025, Brussels-Belgium, 09-13/06/2025.

  • 13th World Congress on Alternatives and Animal Use in the Life Sciences, Rio de Janeiro-Brazil, 31/08-04/09/2025.

Sessions

Organisation of conference sessions

  • “Metabolism and toxicokinetics”, 16th Conference of the European Society for Toxicology In Vitro, Linz-Austria, 02-04/09/2010.

  • “Epigenetics”, 8th World Congress on Alternatives and Animal Use in the Life Sciences, Montréal-Canada, 21-25/08/2011.

  • “Carcinogenicity testing” and “Student session”, 17th Conference of the European Society for Toxicology in Vitro, Lisbon-Portugal, 16-19/10/2012.

  • “Connexin-based cellular signalling and its relevance to toxicology”, 49th Conference of the European Societies of Toxicology, Interlaken-Switzerland, 01-04/09/2013.

  • “New molecular biotechnology in toxicology” and “Job opportunity and career exploration”, 18th Conference of the European Society for Toxicology in Vitro, Egmond aan zee-The Netherlands, 10-13/06/2014.

  • “Pathway approaches in toxicology”, 9th World Congress on Alternatives and Animal Use in the Life Sciences, Prague-Czech Republic, 24-28/08/2014.

  • “The role of connexin-based channels in toxicity”, Society of Toxicology Meeting, San Diego-USA, 22-26/03/2015.

  • “Regulation and traffic of hemichannels and gap junction channels”, International Gap Junction Conference, Valparaiso-Chili, 28/03-01/04/2015.

  • “Implementation of the adverse outcome pathway in HeMiBio”, SEURAT Symposium “Painting the future animal-free safety assessment of chemical substances: achievements of SEURAT-1”, Brussels-Belgium, 04/12/2015.

  • “Systemic toxicity” and “Job opportunity and career exploration”, 19th Conference of the European Society for Toxicology in Vitro, Juan-Les-Pins-France, 17-21/10/2016.

  • “Predicting drug-induced cholestatic injury in humans”, Society of Toxicology Meeting, San Antonio-USA, 11-15/03/2017.

  • “Job opportunity and career exploration”, 20th Conference of the European Society for Toxicology in Vitro, Berlin-Germany, 15-18/10/2018.

  • “Biomarkers in predictive toxicology and risk assessment”, 55th Congress of the European Societies of Toxicology, Helsinki-Finland, 08-11/09/2019.

  • "Emerging tools for the investigation and prediction of liver toxicity”, 57th Congress of the European Societies of Toxicology (Virtual Conference), 27/09-01/10/2021.

  • "Mechanistic toxicology as the basis for modelling and prediction of organ-specific toxicity”, 57th Congress of the European Societies of Toxicology (Virtual Conference), 27/09-01/10/2021.

  • “Next generation risk assessment of chemicals”, ILSI Europe Annual Symposium (virtual event), 05/10/2021.

  • “Onward and upward as an early career scientist”, ILSI Europe Annual Symposium (virtual event), 05/10/2021.

  • “Roundtable discussion: implementation and use of in silico tools for toxicity testing: academic, industrial and regulatory perspectives”, XVIth International Congress of Toxicology, Maastricht-The Netherlands, 18-21/09/2022.

  • "Organ-specific toxic pathways: recent progress in drug-induced adversities", 11th Congress of the Turkish Society of Toxicology, Antalya-Turkey, 02-05/11/2022.

  • "Challenges in the development of generic PBK models for next generation risk assessment”, Society of Toxicology Meeting, Nashville-USA, 19-23/03/2023.

  • "ASPIS: from molecular toxicology to regulatory acceptance: the next steps for animal-free testing”, 12th World Congress on Alternatives and Animal Use in the Life Sciences, Niagara Falls-Canada, 27-31/08/2023.

  • "Acceptance and use of in vitro methods: a perspective from various chemical sectors", 57th Congress of the European Societies of Toxicology, Ljubljana-Slovenia, 10-13/09/2023.

  • "Space nutrition: an inspiration for innovation", ILSI Europe Annual Symposium, Brussels-Belgium, 24-25/10/2023.

  • "MPS for drug safety", 3rd Microphysiological Systems World Summit, Seattle-USA, 10-14/06/2024.

  • "New developments in micro- and nanoplastics research", 58th Congress of the European Societies of Toxicology, Copenhagen-Denmark, 08-11/09/2024.

  • "Young scientist session: emerging researchers in the field of in vitro and in silico toxicology", 58th Congress of the European Societies of Toxicology, Copenhagen-Denmark, 08-11/09/2024.

  • "Ontology-driven and artificial intelligence-based repeated dose toxicity testing of chemicals for next generation risk assessment", 58th Congress of the European Societies of Toxicology, Copenhagen-Denmark, 08-11/09/2024.

  • "PFAS and health: state-of-the-art in some areas of controversy", 58th Congress of the European Societies of Toxicology, Copenhagen-Denmark, 08-11/09/2024.

  • "Microphysiological systems as emerging tools in predictive toxicology", 58th Congress of the European Societies of Toxicology, Copenhagen-Denmark, 08-11/09/2024.

  • "Launching space toxicology as a new frontier research discipline: academic, industrial and intergovernmental agency perspectives”, Society of Toxicology Meeting, Orlando-USA, 16-20/03/2025.

Workshop and courses

Organisation of workshops, symposia and courses

  • Workshop “In vivo extrapolation of in vitro data in toxicology: state-of-the-art and challenges”, Lisbon-Portugal, 20/10/2012.

  • HeMiBio winterschool “Concepts of toxicology and risk assessment”, Barcelona-Spain, 16/01/2013.

  • HeMiBio summerschool “Practical concepts of in vitro and in silico toxicology”, Brussels-Belgium, 04-06/06/2013.

  • 4th ECS workshop “Ca2+ and cell death”, Leuven-Belgium, 11-13/09/2013.

  • SEURAT summerschool, Egmond aan zee-The Netherlands, 07-09/06/2014.

  • HeMiBio winterschool “In vitro biokinetics”, 13/01/2015, Chur-Switzerland.

  • “Applied in vitro toxicology course”, Lisbon-Portugal, 25-29/01/2015.

  • HeMiBio International Symposium “Biology meets technology for liver toxicity testing”, Leuven-Belgium, 02-03/12/2015.

  • “Applied in vitro toxicology course”, Brasilia-Brazil, 20-24/06/2016.

  • “Science Xpression” workshop, La Coruna-Spain, 26-28/09/2016.

  • “Applied in vitro toxicology course”, Belvaux-Luxembourg, 08-13/01/2017.

  • “AOP light course”, Leuven-Belgium, 25/06/2017.

  • “Science Xpression” workshop, Santiago de Compostella/La Coruna-Spain, 25-29/09/2017.

  • “Applied in vitro toxicology course”, Utrecht-The Netherlands, 08-13/04/2018.

  • Continuing Education Course “Organ-specific in vitro modelling: state-of-the-art”, 54th Congress of the European Societies of Toxicology, Brussels-Belgium, 02-05/09/2018.

  • “Science Xpression” workshop, Santiago de Compostella/La Coruna-Spain, 24-28/09/2018.

  • Workshop “AOP: an essential tool in in vitro toxicology”, 20th Conference of the European Society for Toxicology in Vitro, Berlin-Germany, 15-18/10/2018.

  • Workshop “Hands-on training in vitro and in silico toxicology”, 20th Conference of the European Society for Toxicology in Vitro, Berlin-Germany, 15-18/10/2018.

  • “ILSI workshop: use of AOPs in safety evaluation of food additives”, Brussels-Belgium, 26-27/02/2019.

  • “Applied in vitro toxicology course”, Bucharest-Romania, 14-19/04/2019.

  • “Molecular Toxicology Course”, Izmir-Turkey, 26-29/06/2019.

  • “Science Xpression” workshop, La Coruna-Spain, 07-11/10/2019.

  • “PANACHE Science Xpression online workshop”, 06-07/10/2020.

  • “Applied in vitro toxicology course”, Brussels-Belgium, 25-30/10/2020.

  • "ONTOX-VHP4 Safety workshop", Utrecht-The Netherlands, 19/10/2022.

  • "ASPIS NGRA framework online workshop", 27/10/2022.

  • “ASPIS open symposium”, Sitges-Spain, 24-25/11/2022.

  • “ASPIS open symposium”, Ljubljana-Slovenia, 14-15/09/2023.

  • “Cholestatic liver disorders: from bed to benchside”, Leuven-Belgium, 21-22/09/2023.

  • "10th ECS workshop: the Ca2+ signaling toolkit in health and disease”, Leuven-Belgium, 15-17/11/2023.

  • ONTOX Hackathon "Hack to save lives and avoid animal suffering", Utrecht-The Netherlands, 21-23/04/2024.

  • ONTOX-VHP4Safety joint meeting, Utrecht-The Netherlands, 26/04/2024.

  • “2nd Molecular Toxicology Course”, Izmir-Turkey, 22-24/05/2024.

  • "ILSI Europe training "Advancements in toxicological hazard and risk assessment for food safety: exploring new approach methodologies and predictive models", Brussels-Belgium, 28/05-29/08/2024.

Seminars and webinars

Organisation of seminars and webinars

  • Seminar “Mechanisms of cholestatic liver injury: from animal models to humans”, Brussels-Belgium, 06/09/2018.

  • ASCCT/ESTIV webinar “Stem cell-based in vitro models: state-of-the-art tools to predict drug-induced tissue injury in humans”, 23/10/2018.

  • ASCCT/ESTIV webinars “Pairwise toxicity evaluation of ceramic nanoparticles exposure in human alveolar epithelial A549 cells at submerged and air-liquid cultures” and “Reproducible in vitro toxicology testing using functional immortalized cells”, 23/01/2019.

  • ASCCT/ESTIV webinars “Developing mechanism-based animal toxicity models: a chemocentric approach using big data” and “Integrating genomics and epigenomics into predictive toxicology of the AH receptor”, 20/02/2019.

  • ASCCT/ESTIV webinars “Efficient functional cyst formation of biliary epithelial cells using microwells for potential bile duct organisation in vitro” and “Generation of recombinant human anti-diphtheria toxin neutralizing antibody to replace equine sera”, 20/03/2019.

  • ASCCT/ESTIV webinar “Automated and integrated analysis workflow for adverse outcome pathway identification, hypothesis generation and risk assessment”, 25/04/2019.

  • ASCCT/ESTIV webinar “New computational tools from EPA: the CompTox chemicals dashboard and generalized read-across”, 09/05/2019.

  • ASCCT/ESTIV webinar “GARD™air: an in vitro assay to test for respiratory sensitizers using genomic biomarkers and machine learning”, 12/06/2019.

  • Applied In Vitro Toxicology Roundtable discussion “Mitochondrial toxicity”, 20/08/2019.

  • ASCCT/ESTIV webinar “Developmental neurotoxicity evaluation: on the road to regulatory acceptance”, 28/08/2019.

  • ASCCT/ESTIV webinar “Nerve-on-a-chip platform for assessing chemotherapy-induced peripheral neuropathy”, 17/09/2019.

  • ASCCT/ESTIV webinar “Translational challenges in in vitro nephrotoxicity models”, 22/10/2019.

  • ASCCT/ESTIV webinar “The pros and cons of 3D in vitro cultures of liver fibrosis”, 04/11/2019.

  • ASCCT/ESTIV webinar “Deep learning in toxicity prediction: reasons for use and possible applications”, 04/12/2019.

  • ASCCT/ESTIV webinars “Role of in vitro mechanistic data for the assessment of endocrine disruptors in the regulatory context” and “A battery of animal-free in vitro assays for evaluating prenatal developmental toxicity potency of highly complex petroleum substances”, 21/01/2020.

  • ASCCT/ESTIV webinar “Moving away from animal testing for acute inhalation toxicity testing”, 25/02/2020.

  • ASCCT/ESTIV webinars “Toxicological mechanistic inference: generating mechanistic explanations of adverse outcomes” and “co-expression network analysis to identify heterogeneity between the breast cancer cell line MCF-7 and human breast cancer tissues”, 11/03/2020.

  • AlterTox Academy webinar "Secrets for winning a grant and coping when losing it", 11/09/2020.

  • EUROTOX in vitro and in silico specialty section webinar "Role of in vitro and in silico methodologies in COVID-19 research", 17/09/2020.

  • EUROTOX in vitro and in silico specialty section webinar "Role of in vitro and in silico methodologies in COVID-19 research", 18/01/2021.

  • FWO-SRN webinar “Modelling and prediction of liver toxicity: focus on drug-induced cholestasis”, 21/01/2021.

  • FWO-SRN webinar “Unraveling distinct immune cell populations and the disturbed gut-liver crosstalk in primary sclerosing cholangitis and related ulcerative colitis”, 27/04/2021.

  • ONTOX webinar “Artificial intelligence”, 14/05/2021.

  • ONTOX webinar “PBPK and QIVIVE”, 21/05/2021.

  • ONTOX webinar “Read-across and QSAR”, 28/05/2021.

  • ONTOX webinar “NGRA”, 11/06/2021.

  • FWO-SRN webinar “Transporter alterations in drug-induced cholestasis”, 01/07/2021.

  • FWO-SRN webinar “Role of Panx1 channel and Cx43 (hemi)channel on murine hepatocarcinogenesis: preliminary data”, 25/10/2021.

  • ONTOX webinar "read-across-based structure-activity relationship", 10/01/2022.

  • FWO-SRN webinar “Bile acid toxicity in cholestatic liver disease”, 12/01/2022.

  • ONTOX webinar “General principles of validation of NAMs”, 14/01/2022.

  • EUROTOX in vitro and in silico specialty section webinar "The use of artificial intelligence in toxicology", 18/01/2022.

  • ONTOX webinar “General principles of REACH legislation”, 21/01/2022.

  • ONTOX webinar “Safety evaluation of cosmetic products”, 28/01/2022.

  • EUROTOX in vitro and in silico specialty section webinar "Adverse outcome pathways", 22/02/2022.

  • EUROTOX in vitro and in silico specialty section webinar "Kidney-based in vitro modelling", 17/03/2022.

  • FWO-SRN webinar “The role of Kupffer cells in chronic liver disease”, 19/04/2022.

  • EUROTOX in vitro and in silico specialty section webinar "Next generation physiologically based kinetic modelling: challenges and opportunities", 25/05/2022.

  • ONTOX webinar “Way forward and future perspectives for NAMs”, 10/06/2022.

  • EUROTOX in vitro and in silico specialty section webinar "QSAR and read-across in the assessment of plant protection products", 14/06/2022.

  • ONTOX webinar “REACH data requirements and upcoming revisions”, 17/06/2022.

  • ONTOX webinar “Current and future challenges of safety evaluation for cosmetics”, 24/06/2022.

  • FWO-SRN webinar “Identification of a novel candidate to promote hepatic maturation in HepG2 cells in vitro​”, 06/07/2022.

  • FWO-SRN webinar “Development of a physiological  map of bile secretion and an adverse outcome pathway of cholestasis”, 12/10/2022.

  • FWO-SRN webinar “Effects of PFAS on the liver: focus on cholestasis”, 10/01/2023.

  • ONTOX webinar “Intellectual property rights”, 20/01/2023.

  • ONTOX webinar “Intellectual property rights and FAIR principles”, 27/01/2023.

  • FWO-SRN webinar “Serum biomarkers for primary sclerosing cholangitis”, 17/04/2023.

  • FWO-SRN webinar “Role of pannexin1 channels and Cx43 hemichannels in hepatocarcinogenesis and cancer-associated fibroblasts”, 12/06/2023.

  • FWO-SRN webinar “Physiologically-based kinetic modeling of human bile acid handling after administration of bosentan”, 16/10/2023.

  • FWO-SRN webinar “Set-up of an in vitro 3D spheroid co-culture model to predict cholestatic drug-induced liver injury”, 10/01/2024.

  • FWO-SRN webinar "Deubiquitinase UCHL1 targeting as part of new combinatorial treatments for hepatocellular carcinoma", 18/04/2024.

  • FWO-SRN webinar "A stem cell-based in vitro test battery to predict liver steatotic potential of diverse chemicals", 02/07/2024.

bottom of page